Zobrazeno 1 - 10
of 715
pro vyhledávání: '"D. Lillicrap"'
Autor:
I Oomen, RM Camelo, M Carcao, G Castaman, JCJ Eikenboom, K Fischer, WG Frank Leebeek, D Lillicrap, ME Mancuso, D Matino, DMN Di Minno, AB Mohseny, J Oldenburg, SM Rezende, GE Rivard, N Rydz, S Schols, Voorberg Jan, FMRA Callado, LEM Carvalho, VKB Franco, CS Lorenzato, K Fijnvandraat, S Gouw
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S562-S563 (2024)
Background: Eradicating inhibitors to restore the effectiveness of Factor VIII (FVIII) is a desirable treatment goal for People with Severe Hemophilia A (PwSHA) and inhibitors, as this enables treatment of bleeding episodes with FVIII concentrates. H
Externí odkaz:
https://doaj.org/article/9a14647d2e784f2e9ac3886aafab9e62
Autor:
I Oomen, A Abdi, L Broer, RM Camelo, FMRA Callado, LEM Carvalho, IL Calcaterra, M Carcao, G Castaman, JCJ Eikenboom, K Fischer, VKB Franco, J Geissler, TW Kuijpers, FWG Leebeek, D Lillicrap, CS Lorenzato, ME Mancuso, D Matino, MND Di Minno, A Mo, AB Mohseny, SQ Nagelkerke, J Oldenburg, SM Rezende, K Fijnvandraat, S Gouw
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S564- (2024)
Immune Tolerance Induction (ITI) is the only treatment to eradicate inhibitors in people with Severe Hemophilia A (SHA). Successful ITI restores Factor VIII (FVIII) tolerance. ITI is demanding and successful in approximately 70% of people. Therefore,
Externí odkaz:
https://doaj.org/article/8a4854d5cc734792892446f0a32e01ce
Autor:
P, Batty, A M, Mo, D, Hurlbut, J, Ishida, B, Yates, C, Brown, L, Harpell, C, Hough, A, Pender, E K, Rimmer, S, Sardo Infirri, A, Winterborn, S, Fong, D, Lillicrap
Publikováno v:
Blood. 140:2672-2683
Questions remain concerning the long-term efficacy, safety, and site(s) of transgene expression following adeno-associated vector (AAV) therapy. We report a long-term follow-up of 8 (male = 4, hemizygous, and female = 4, homozygous) dogs with severe
Autor:
Jihae Park, Eun-Jin Yoo, Kisik Shin, Stephen Depuydt, Wei Li, Klaus-J. Appenroth, Adam D. Lillicrap, Li Xie, Hojun Lee, Geehyoung Kim, Jonas De Saeger, Soyeon Choi, Geonhee Kim, Murray T. Brown, Taejun Han
Publikováno v:
Biology, Vol 11, Iss 1, p 37 (2021)
The common duckweed (Lemna minor), a freshwater monocot that floats on the surfaces of slow-moving streams and ponds, is commonly used in toxicity testing. The novel Lemna root- regrowth test is a toxicity test performed in replicate test vessels (24
Externí odkaz:
https://doaj.org/article/7c0b003641764530ae0840df02c249ba
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jihae Park, Eun-Jin Yoo, Kisik Shin, Stephen Depuydt, Wei Li, Klaus-J. Appenroth, Adam D. Lillicrap, Li Xie, Hojun Lee, Geehyoung Kim, Jonas De Saeger, Soyeon Choi, Geonhee Kim, Murray T. Brown, Taejun Han
Publikováno v:
Biology, Vol 11, Iss 37, p 37 (2022)
BIOLOGY-BASEL
Biology
Biology (Basel)
Biology; Volume 11; Issue 1; Pages: 37
BIOLOGY-BASEL
Biology
Biology (Basel)
Biology; Volume 11; Issue 1; Pages: 37
Simple Summary Duckweed (Lemna minor) is commonly used as a phytotoxicity test organism, adopted by the main international standardization organizations (ISO, OECD, USEPA, ASTM). For duckweed tests, measurements of fronds or biomass are usually prefe
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Stefanie DiGiandomenico, Pamela A. Christopherson, Sandra L. Haberichter, Thomas C. Abshire, Robert R. Montgomery, Veronica H. Flood, L. Valentino, T. Abshire, A. Dunn, C. Bennett, J. Lusher, M. Rajpurkar, W.K. Hoots, D. Brown, A. Shapiro, J. Di Paola, S. Lentz, J. Gill, C. Leissinger, M. Ragni, J. Hord, M. Manco‐Johnson, A. Ma, L. Boggio, A. Sharathkumar, R. Gruppo, B. Kerlin, J. Journeycake, R. Kulkarni, D Mahoney, L. Mathias, A. Bedros, C. Diamond, A. Neff, A. Paroskie, D. DiMichele, P. Giardina, A. Cohen, M. Paidas, E. Werner, A. Matsunaga, T. Singer, M. Tarantino, J. Roberts, F. Shafer, B. Konkle, A. Cuker, P. Kouides, D. Stein, D. Lillicrap, P. James
Publikováno v:
J Thromb Haemost
Essentials Patients with von Willebrand disease were enrolled in our study. Type 2 VWD diagnoses were based on original test results. Repeat evaluation resulted in many patients receiving a different type 2 diagnosis. Some genetic variants were parti
Autor:
Pamela A. Christopherson, Sandra L. Haberichter, Veronica H. Flood, Crystal L. Perry, Brooke E. Sadler, Daniel B. Bellissimo, Jorge Di Paola, Robert R. Montgomery, T Abshire, H Weiler, D Lillicrap, P James, J O’Donnell, C Ng, C Bennett, R Sidonio, M Manco‐Johnson, J Journeycake, A Zia, J Lusher, M Rajpurkar, A Shapiro, S Lentz, J Gill, C Leissinger, M Ragni, M Tarantino, J Roberts, J Hord, J Strouse, A Ma, L Valentino, L Boggio, A Sharathkumar, R Gruppo, B Kerlin, R Kulkarni, D Green, K Hoots, D Brown, D Mahoney, L Mathias, A Bedros, C Diamond, A Neff, D DiMichele, P Giardina, A Cohen, M Paidas, E Werner, A Matsunaga, F Shafer, B Konkle, A Cuker, P Kouides, D Stein
Publikováno v:
Journal of thrombosis and haemostasis : JTHREFERENCES. 20(7)
Type 3 von Willebrand Disease (VWD) is a rare and severe form of VWD characterized by the absence of von Willebrand factor (VWF).As part of the Zimmerman Program, we sought to explore the molecular pathogenesis, correlate bleeding phenotype and sever